CLINICAL_TRIALS
trial_result
· 2025-12-16
Clinical Trial Update: Deucravacitinib for the Treatment of Palmoplantar Pustulosis [Phase 4]
Summary
A Phase 4 trial evaluating deucravacitinib for palmoplantar pustulosis was terminated, with results posted on 2025-12-16.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Brigham and Women's Hospital | Conditions: Palmoplantar Pustulosis | Phase 4 | Status: TERMINATED | Results posted: 2025-12-16